Triple combination of antibiotics could be the new arsenal against drug-resistant bacteria

FHS
June 4, 2024
5:59 pm

In the ongoing battle against antibiotic resistance, a new study published in Engineering by Zhuoren Ling’s research team unveils a promising triple combination of antibiotics that significantly expands our arsenal against drug-resistant bacteria.

Merck Merck KGaA acquires Mirus Bio

Mirus Bio’s GMP transfection re-agents complement Merck’s upstream bioprocessing portfolio. Credit: Merck KGaA, Darmstadt, Germany and/or its affiliates. Germany-based Merck KGaA has concluded the acquisition

August 2, 2024

Coronary Disease That Comes With a Donor Heart Does Carry Risk

Coronary artery disease (CAD) that comes with a donor heart was not uncommon and conferred cardiovascular risk, although not an early death overall, according to

August 23, 2023

Medicaid Expansion led to increased access to preventive care for low-income adults

People with low incomes who live in states that expanded Medicaid got more of the kind of health care that can keep them healthier in

July 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.